Long-Term Side Effects of CPAP Machine

Long-term side effects of CPAP machine use include persistent dry mouth, nasal congestion, skin irritation from the mask, aerophagia (air swallowing), and, in some cases, changes in facial structure with prolonged use. According to the American Academy of Sleep Medicine, continuous positive airway pressure remains the gold-standard treatment for obstructive sleep apnea, but sustained adherence depends on managing these side effects effectively. This article is for anyone currently using CPAP therapy, considering starting treatment, or exploring whether long-term pressurized air delivery carries hidden health risks. You will find a breakdown of the most commonly reported physical side effects, the less obvious systemic effects that emerge over months and years, practical strategies to reduce discomfort, and how sleep quality tracked through biomarkers connects CPAP therapy to biological aging. Understanding the full picture helps you stay on therapy longer and protect your longevity, not just your airway.

Quick Answer

Long-term side effects of CPAP machine use most commonly include dry mouth, nasal congestion, skin irritation, aerophagia, mask discomfort, and occasional respiratory infections from poorly maintained equipment. More nuanced effects such as changes in midface structure, persistent air leakage issues, and claustrophobia-driven non-adherence can emerge over years of therapy. These side effects are manageable with proper mask fit, humidification, and clinical follow-up. Dumbo Health provides biomarker-driven sleep longevity tracking and physician-supported CPAP care pathways that help members monitor how therapy is affecting their health over time.

Key Takeaways

• CPAP therapy is the most effective non-surgical treatment for obstructive sleep apnea, but long-term use carries manageable side effects including dry mouth, nasal congestion, skin irritation, and aerophagia
• Poor mask fit is the single most correctable cause of CPAP side effects, and choosing the right mask style (nasal pillow, nasal mask, or full mask) reduces most comfort complaints
• Untreated sleep apnea accelerates biological aging through elevated blood pressure, systemic inflammation, and metabolic disruption, making the side effects of CPAP therapy far less harmful than the disease it treats
• A heated humidifier eliminates or significantly reduces dry mouth, dry nose, and nasal congestion for most CPAP users
• Dumbo Health's Core membership at $0.99 a day tracks 51 sleep-longevity biomarkers twice a year, giving CPAP users a way to measure whether therapy is actually reversing the metabolic and cardiovascular damage caused by sleep apnea
• Regular follow-up with a sleep physician, including pressure settings review and residual AHI monitoring, prevents most long-term complications from worsening

Why CPAP Side Effects Deserve Serious Attention Even When Therapy Works

CPAP side effects matter because they are the primary reason patients stop therapy, and stopping therapy reactivates every health risk that obstructive sleep apnea creates. The National Heart, Lung, and Blood Institute estimates that CPAP adherence rates hover around 50 percent at the one-year mark, largely because side effects erode nightly compliance. When a patient tolerates pressurized air delivery well, positive airway pressure therapy reduces cardiovascular disease risk, lowers blood pressure, improves sleep architecture, and protects cognitive function. When side effects drive someone off therapy, those protections vanish.

The distinction between short-term discomfort and genuine long-term side effects is clinically important. A new CPAP user who experiences nasal congestion during the first two weeks is dealing with an adjustment issue. A patient who develops chronic sinusitis or persistent pressure sores after 18 months of use is experiencing a long-term side effect that requires intervention.

This article separates the two categories and addresses what actually happens to your body, your airway, and your broader health profile after months and years of nightly CPAP machine use.

DID YOU KNOW: According to the Sleep Foundation, roughly 30 to 50 percent of CPAP users report at least one persistent side effect that affects their willingness to continue therapy, making side effect management as clinically important as the initial diagnosis itself.

KEY TAKEAWAY: CPAP side effects are the leading driver of therapy abandonment, and abandoning therapy reactivates every health risk that obstructive sleep apnea creates, from elevated blood pressure to accelerated biological aging.

Understanding the specific physical side effects is the first step toward managing them, so the next section breaks down each one in clinical detail.

The Most Common Long-Term Physical Side Effects of CPAP Machines

The most frequently reported long-term physical side effects of CPAP machine use are dry mouth, nasal congestion, skin irritation, aerophagia, mask discomfort, and condensation-related issues in the tubing. Each of these side effects has a well-understood mechanism and a corresponding fix, which means most patients can stay on therapy indefinitely once they identify which side effects affect them.

Dry Mouth and Dry Nose

Dry mouth is the single most common complaint among long-term CPAP users. Pressurized air delivered through a nasal mask or nasal pillow can cause mouth breathing, which dries out oral tissues overnight. Dry nose results from the same mechanism: continuous airflow through the nasal passages strips moisture from the mucosal lining.

The fix is almost always a heated humidifier integrated into the CPAP device. Most modern CPAP machines, including models in the DreamStation and AirSense product lines, include a humidifier chamber that adds moisture to the airflow. A chin strap can also reduce mouth leak for nasal mask users, keeping pressurized air in the nasal airway rather than escaping through an open mouth.

Persistent dry mouth that does not resolve with humidification and a chin strap may indicate that the mask style is wrong for the patient. Switching from a nasal pillow to a full mask often resolves the issue entirely.

Nasal Congestion and Sinusitis

Long-term CPAP therapy can cause chronic nasal congestion in some patients, particularly when humidification levels are set too low or when the air pressure irritates the nasal passages. In rare cases, prolonged nasal congestion progresses to sinusitis, an inflammation of the sinus cavities that may require medical treatment.

The Mayo Clinic notes that nasal saline rinses, topical nasal corticosteroids, and adjusting humidifier settings resolve nasal congestion in most CPAP users. Patients who experience recurring sinusitis should discuss alternative mask styles or bilevel positive airway pressure with their sleep physician, as reducing peak pressure can alleviate sinus irritation.

Skin Irritation, Dermatitis, and Pressure Sores

Mask-related skin irritation is a long-term side effect that ranges from mild redness to contact dermatitis and pressure sores on the nasal bridge, cheeks, or forehead. The severity depends on mask fit, mask material, and how tightly the headgear is secured.

Mask liners, which are thin fabric barriers placed between the mask cushion and the skin, reduce friction and absorb moisture. Patients who develop persistent dermatitis may have a sensitivity to silicone or other mask materials and should explore hypoallergenic mask options. Rotating between two mask styles, such as alternating a nasal pillow with a nasal mask, distributes contact pressure across different facial areas and prevents localized tissue breakdown.

Pressure sores that do not heal within a few days of mask adjustment require clinical evaluation. A poorly fitting mask that causes ongoing tissue damage is a sign that the mask size, mask style, or headgear tension needs to change.

Aerophagia: Air Swallowing

Aerophagia is the medical term for swallowing pressurized air, which causes bloating, gas, belching, and abdominal discomfort. It is one of the more disruptive long-term side effects of CPAP therapy because it can interrupt sleep and discourage nightly use.

Aerophagia becomes more common at higher air pressure settings. Patients on fixed-pressure CPAP machines set above 12 cm H2O are more likely to experience this side effect. Switching to an auto CPAP device, which adjusts pressure dynamically based on real-time airflow monitoring, often reduces aerophagia by lowering pressure during exhalation and periods of stable breathing.

Sleeping in a slightly elevated position and avoiding large meals before bed can also reduce the frequency of air swallowing episodes.

Claustrophobia and Mask Discomfort

Claustrophobia associated with wearing a CPAP mask does not always resolve with time. Some patients tolerate therapy well initially but develop increasing anxiety about mask wear after months of use. This is a genuine long-term side effect, not simply an adjustment issue.

Nasal pillow masks, which sit at the entrance of the nostrils rather than covering the nose or face, produce significantly less claustrophobic response than full masks. A hybrid mask, which combines nasal pillows with a mouth cover, offers another option for patients who need full airway coverage but cannot tolerate a traditional full mask.

Desensitization techniques, such as wearing the mask while awake during relaxing activities before using it for sleep, can help reduce claustrophobia over time. If claustrophobia remains severe enough to prevent CPAP adherence, oral appliance therapy or surgical intervention may be discussed with a sleep physician.

Condensation and Tube Rainout

Condensation inside the CPAP tube, sometimes called rainout, occurs when warm humidified air cools as it travels through the tubing to the mask. Water droplets accumulate and can splash onto the face or into the airway, causing coughing, sputtering, or fragmented sleep.

A heated tube solves this problem by maintaining consistent air temperature throughout the delivery path. Most current-generation CPAP devices offer heated tubing as a standard accessory.

KEY TAKEAWAY: Every common long-term CPAP side effect, from dry mouth to aerophagia to condensation, has a well-documented solution, and the majority of fixes involve adjusting humidification, mask fit, or pressure settings rather than discontinuing therapy.

Beyond the physical discomfort, CPAP therapy also has less obvious effects on systemic health markers that only become visible through clinical tracking.

How Long-Term CPAP Use Affects Blood Pressure, Cardiovascular Risk, and Metabolic Health

Long-term CPAP therapy has measurable effects on blood pressure, cardiovascular disease risk, and metabolic health, but those effects depend heavily on adherence, meaning how many hours per night and how many nights per week the machine is actually used. The relationship between CPAP and these systemic health markers is one of the most studied areas in sleep medicine.

Blood Pressure Reduction

Obstructive sleep apnea drives sympathetic hyperactivity, a state of chronic nervous system arousal that elevates both systolic blood pressure and diastolic blood pressure. According to the NIH, CPAP therapy used for at least 4 hours per night reduces systolic blood pressure by approximately 2 to 3 mmHg on average. That reduction is modest compared to hypertensive drugs such as beta-blockers or calcium channel blockers, but it compounds meaningfully over years and contributes to reduced stroke and heart disease risk.

Patients with resistant hypertension, defined as blood pressure that remains elevated despite three or more medications, show greater blood pressure response to CPAP therapy than the general sleep apnea population. Research published in peer-reviewed journals indexed on PubMed has demonstrated that treating obstructive sleep apnea in this group with long-term continuous positive airway pressure treatment can lower blood pressure enough to reduce or eliminate one antihypertensive medication. The long-term antihypertensive effects are most pronounced in patients who use CPAP for more than 6 hours per night.

Cardiovascular Disease Risk and Arrhythmia

Untreated sleep apnea increases the risk of heart disease, stroke, and arrhythmia, particularly atrial fibrillation. Long-term CPAP therapy reduces the recurrence of atrial fibrillation episodes in patients who have undergone ablation or cardioversion, according to data reviewed by the American Academy of Sleep Medicine. However, CPAP is not a standalone cardiovascular treatment. It works best as part of a broader risk-reduction strategy that includes blood pressure management, body weight regulation, and metabolic health monitoring.

Arterial stiffness, a marker of vascular aging, has been shown to improve in some studies of long-term CPAP users, though results vary. Tracking cardiovascular biomarkers such as ApoB and hs-CRP over time provides a clearer picture of whether CPAP therapy is genuinely reducing a patient's cardiovascular disease risk or simply treating the airway obstruction without addressing downstream damage.

Dumbo Health's sleep longevity biomarker panels include inflammatory and cardiovascular markers that allow CPAP users to see whether their therapy is translating into measurable health improvement, not just symptom relief.

Body Weight, Metabolic Rate, and Appetite Regulation

Obstructive sleep apnea disrupts metabolic hormones. Ghrelin plasma levels, which drive hunger, tend to be elevated in untreated sleep apnea patients, while leptin resistance, which impairs satiety signaling, is more common. Long-term CPAP therapy partially normalizes these hormone levels, making body weight regulation easier for patients who were previously unable to lose weight despite caloric restriction.

However, CPAP therapy alone does not cause weight loss. It removes a metabolic obstacle. Patients who combine CPAP adherence with dietary changes, physical activity, and clinical monitoring of metabolic biomarkers see the most meaningful improvements in body-mass index and abdominal circumference.

The connection between sleep apnea, metabolic health, and biological aging is central to Dumbo Health's approach. The SleepLongevityAge metric tracks how sleep-related biomarkers such as HbA1c, fasting glucose, hs-CRP, and cortisol are shifting over time, giving CPAP users a concrete number that reflects whether therapy is slowing or reversing the aging process.

CPAP therapy can reduce blood pressure, lower cardiovascular risk, and improve metabolic health markers, but only when used consistently for at least 4 to 6 hours per night. Intermittent use produces minimal long-term benefit.

KEY TAKEAWAY: Long-term CPAP use has real systemic health benefits beyond keeping the airway open, but those benefits only materialize with consistent nightly adherence and are best tracked through longitudinal biomarker monitoring rather than symptom assessment alone.

The cardiovascular and metabolic benefits of CPAP raise an important question: does therapy actually slow biological aging, and how would you measure that?

CPAP Therapy and Biological Aging: What the Biomarker Evidence Shows

CPAP therapy slows biological aging by reducing the chronic physiological stress that untreated obstructive sleep apnea inflicts on the cardiovascular, metabolic, and immune systems. The mechanism is indirect but significant: sleep apnea causes repeated oxygen desaturation events every night, which triggers systemic inflammation, oxidative stress, and sympathetic nervous system activation. Over years, these processes accelerate cellular aging in ways that show up in blood biomarkers and, eventually, in epigenetic clocks.

How Sleep Apnea Accelerates Aging at the Biomarker Level

Each apnea event drops blood oxygen levels and forces the body into a stress response. Over months and years, this cycle elevates hs-CRP (a marker of systemic inflammation), raises cortisol levels, increases insulin resistance (reflected in HbA1c), and drives up ApoB (a marker of atherogenic lipid particles). These are not just sleep metrics. They are longevity biomarkers that predict cardiovascular events, metabolic disease, and all-cause mortality.

The National Institute on Aging notes that biological age can diverge meaningfully from chronological age, which is why a single birthday-based number tells an incomplete story. A 48-year-old with untreated severe sleep apnea may have the vascular and inflammatory profile of someone 10 to 15 years older.

What CPAP Changes in the Blood Over Time

Longitudinal studies indexed on PubMed show that consistent CPAP use over 6 to 12 months reduces hs-CRP levels, improves HRV (heart rate variability, a marker of autonomic nervous system health), and in some cases lowers HbA1c. The magnitude of improvement depends on baseline severity, adherence hours, and whether the patient addresses other lifestyle factors concurrently.

What most CPAP users lack is a structured way to track these improvements. A standard sleep study confirms that the apnea-hypopnea index has improved, but it says nothing about whether inflammation is dropping, whether metabolic function is recovering, or whether biological age is shifting in the right direction.

This is the gap that Dumbo Health's SleepLongevityAge metric fills. Built from 51 blood biomarkers in the Core membership (or 103 in the Concierge plan), the score quantifies how sleep is accelerating or slowing biological aging. For CPAP users, it provides a longitudinal view of whether therapy is translating into real cellular-level recovery, tested twice a year through the Quest Diagnostics network at more than 2,000 locations nationwide.

Why the Apnea-Hypopnea Index Alone Is Not Enough

The apnea-hypopnea index (AHI) measures how many breathing interruptions occur per hour of sleep. It is the standard diagnostic and monitoring metric for obstructive sleep apnea. Residual AHI while on CPAP tells clinicians whether the device is mechanically controlling the airway obstruction.

But AHI does not measure the downstream damage that years of untreated apnea already caused. A patient whose AHI drops from 42 to 3 on CPAP has excellent airway control, but may still carry elevated inflammation, impaired glucose metabolism, and vascular stiffness from the years before diagnosis. Without biomarker tracking, this damage remains invisible.

The most clinically useful approach combines AHI monitoring (which confirms CPAP is working mechanically) with biomarker tracking (which confirms the body is actually recovering). Dumbo Health provides both pathways: CPAP therapy management through its clinical care pathway and biomarker-driven longevity tracking through its membership plans.

KEY TAKEAWAY: CPAP therapy can slow biological aging by reducing chronic inflammation, oxidative stress, and metabolic disruption, but measuring that effect requires biomarker tracking beyond the apnea-hypopnea index.

Knowing what CPAP does and does not fix at the systemic level leads to a practical question: how do you manage the side effects well enough to stay on therapy long enough to see those benefits?

A Step-by-Step Process for Managing Long-Term CPAP Side Effects

Managing CPAP side effects over the long term is a process, not a one-time fix. The side effects that bother you at month 3 may differ from those that emerge at month 18, and your body, sleep habits, and CPAP device settings all change over time. Following a structured approach ensures that side effects get caught early and resolved before they undermine adherence.

How to Systematically Address CPAP Side Effects

1. Identify your primary complaint by keeping a simple sleep log for one week, noting which side effect (dry mouth, mask leak, nasal congestion, skin irritation, aerophagia, or claustrophobia) disrupts your sleep most often
2. Check your mask fit by ensuring the headgear is snug but not overtightened, and verify that the mask style (nasal pillow, nasal mask, full mask, or hybrid mask) matches your breathing pattern and facial structure
3. Adjust your humidification settings by increasing the heated humidifier level incrementally until dry mouth and dry nose symptoms resolve, and switch to a heated tube if condensation becomes a problem
4. Review your pressure settings with your sleep physician, particularly if aerophagia or air leakage has developed, and ask whether switching to an auto CPAP or bilevel positive airway pressure device would reduce exhalation pressure discomfort
5. Replace worn components on schedule by swapping mask cushions every 1 to 3 months, headgear every 6 months, and the humidifier chamber as recommended by the manufacturer, since degraded materials cause mask leak and skin irritation
6. Schedule a clinical follow-up at least once per year that includes a review of your CPAP data (using software such as resScan or OSCAR), your residual AHI, mask leak rates, and usage hours per night
7. Take the free sleep quiz at Dumbo Health to see whether biomarker testing could show if your CPAP therapy is translating into measurable improvements in sleep-longevity biomarkers, not just airway control

After completing these steps, most long-term CPAP users find that their primary side effects are either eliminated or reduced to a level that no longer threatens nightly adherence. The goal is not zero discomfort. It is sustainable therapy that protects your health for decades.

KEY TAKEAWAY: Managing CPAP side effects requires a structured, iterative process that addresses mask fit, humidification, pressure settings, and clinical follow-up rather than relying on willpower alone.

With a clear management process in place, the next question is whether there are situations where CPAP side effects or limitations mean therapy is genuinely the wrong choice.

Limitations, Risks, and When CPAP Therapy May Not Be the Right Choice

CPAP therapy is effective for most patients with obstructive sleep apnea, but it is not universally appropriate and does carry limitations that honest clinical guidance should acknowledge. Understanding these boundaries helps patients make informed decisions rather than abandoning therapy out of frustration or continuing therapy that is not addressing their actual problem.

Central Sleep Apnea Requires a Different Approach

CPAP is designed for obstructive sleep apnea, where the airway physically collapses during sleep. Central sleep apnea, in which the brain fails to send proper breathing signals, does not respond to standard CPAP therapy and may actually worsen on fixed-pressure devices. Patients diagnosed with central sleep apnea or complex sleep apnea (a combination of obstructive and central events) typically require adaptive servo-ventilation or bilevel positive airway pressure with a backup respiratory rate. Using a standard CPAP machine for central sleep apnea is a clinical mismatch that will not resolve symptoms and may create new ones.

Severe Claustrophobia That Does Not Respond to Desensitization

Some patients have claustrophobia severe enough that no mask style, including nasal pillow masks, is tolerable over the long term. Behavioral desensitization helps many people, but a subset of patients cannot achieve consistent CPAP adherence regardless of the approach. For these individuals, oral appliance therapy, which uses a custom-fitted device to reposition the jaw and keep the airway open, offers a non-mask alternative. The American Academy of Sleep Medicine recommends oral appliances for patients with mild to moderate obstructive sleep apnea who cannot tolerate CPAP, and dental sleep medicine specialists can evaluate candidacy. Surgery is another option in select cases, though long-term efficacy varies by procedure type.

Facial Structure Changes With Prolonged Use

A less commonly discussed limitation involves long-term effects on midface development, primarily reported in pediatric populations. Studies indexed on PubMed have raised concerns that years of mask pressure on the growing face can influence maxillary development in children. In adults, the risk of structural facial change is lower but not zero. Patients who wear tightly fitting masks for a decade or more may notice slight indentations or soft tissue changes at common pressure points. Rotating mask styles and ensuring proper fit minimizes this risk.

Residual Sleepiness Despite Adequate Therapy

Some patients continue to experience excessive daytime sleepiness even after CPAP normalizes their AHI and oxygen levels. This condition, sometimes called residual sleepiness, suggests that obstructive sleep apnea was not the sole cause of their fatigue. Cognitive impairment, sleep architecture disruption, or other coexisting conditions may be contributing. Relying on the Epworth Sleepiness Scale alone to assess treatment response can miss deeper issues that require separate evaluation.

Dumbo Health helps address this gap by tracking biomarkers that reveal metabolic, hormonal, and inflammatory contributors to fatigue beyond what a polysomnography or CPAP data download can show.

Patients in States Without Telehealth Coverage

Dumbo Health's clinical sleep apnea pathway, including physician diagnosis and CPAP prescription, is currently available only in Florida, Texas, Virginia and Maryland, and that includes the at-home sleep test. Patients outside these states can still access the biomarker-driven longevity membership and blood draws through the Quest Diagnostics network, but cannot enroll in the at-home sleep test or the CPAP plan.

KEY TAKEAWAY: CPAP therapy has genuine limitations including ineffectiveness for central sleep apnea, unresolvable claustrophobia in some patients, potential facial structure effects over decades, and residual sleepiness that CPAP alone cannot fix. Acknowledging these limits helps patients choose the right treatment, not just the default one.

Real-world examples help illustrate how these side effects and limitations play out for actual CPAP users over time.

How Long-Term CPAP Side Effects Show Up in Real Life

Abstract side effect lists are useful for understanding categories of risk, but the way CPAP side effects actually present in daily life depends on the individual patient's anatomy, CPAP device configuration, and follow-up care. The following scenarios reflect common patterns that clinicians frequently observe in long-term CPAP populations.

Real-World Scenarios

A 52-year-old executive with a body-mass index of 34 and a family history of cardiovascular disease started CPAP therapy after a polysomnography confirmed severe obstructive sleep apnea syndrome with an AHI of 38. His blood pressure at baseline was 148/92 mmHg on two medications. After 14 months of consistent CPAP use at 6.5 hours per night, his systolic blood pressure dropped to 136/84 mmHg and his physician was able to reduce one antihypertensive medication. However, he developed persistent skin irritation on his nasal bridge from the nasal mask. Switching to a nasal pillow mask and applying a mask liner eliminated the dermatitis within two weeks. He later enrolled in Dumbo Health's Core membership to track whether his hs-CRP and ApoB levels were improving alongside his blood pressure.

A 39-year-old woman who works rotating shifts was diagnosed with moderate obstructive sleep apnea (AHI of 22) and prescribed an auto CPAP device. She tolerated the pressure settings well but experienced chronic dry mouth despite using a heated humidifier set to maximum. Her sleep physician identified that she was a mouth breather during sleep and added a chin strap, which resolved the dry mouth within one week. After 8 months, she noticed bloating and abdominal discomfort that her physician attributed to aerophagia at higher auto-titrating pressures. Switching to Bi-level PAP, which delivers lower pressure during exhalation, resolved the aerophagia. Her adherence improved from 4.2 hours per night to 6.8 hours.

A 67-year-old retired truck driver with obstructive sleep apnea, resistant hypertension, and a neck circumference of 18 inches had been on CPAP therapy for 11 years. He maintained excellent adherence but had never checked his residual AHI or tracked any biomarkers beyond what his annual physical covered. After enrolling in Dumbo Health's Concierge membership, his biannual blood draw revealed elevated hs-CRP and a HbA1c of 6.3 percent, both suggesting that his sleep apnea treatment was controlling his airway but had not reversed the metabolic damage accumulated over the decade before his diagnosis. His dedicated sleep physician adjusted his treatment plan to include metabolic monitoring and lifestyle modifications alongside continued CPAP use.

KEY TAKEAWAY: Long-term CPAP side effects and outcomes vary widely between individuals, which is why personalized follow-up, mask adjustments, and biomarker tracking produce better results than a set-and-forget approach to therapy.

These scenarios demonstrate why a checklist-based approach to CPAP maintenance helps prevent side effects from compounding over time.

Your Annual CPAP Health Checklist

Staying ahead of long-term CPAP side effects requires a recurring review of your equipment, your body's response, and your clinical data. Most side effects that drive therapy abandonment after the first year are preventable with regular attention to a short list of maintenance and health items.

Annual CPAP and Sleep Health Review Checklist

• Verify your mask fit has not degraded by checking for increased mask leak readings on your CPAP device data
• Replace mask cushions, headgear, and tubing according to manufacturer schedules to prevent material degradation
• Clean or replace your humidifier chamber to prevent bacterial buildup that can contribute to respiratory infections
• Review your CPAP pressure settings with a sleep physician, especially if you have gained or lost more than 10 pounds since your last titration
• Check your residual AHI through CPAP data software (such as resScan or OSCAR) to confirm your current settings are adequately controlling apnea events
• Assess whether nasal congestion, dry mouth, or skin irritation has worsened since your last review and adjust humidification, mask style, or mask liners accordingly
• Evaluate whether aerophagia, claustrophobia, or condensation issues have changed over the past year
• Schedule a blood draw through Dumbo Health's testing network to track sleep-longevity biomarkers such as hs-CRP, HbA1c, cortisol, and cardiovascular markers

• Take the free sleep quiz and, if you have not yet established your SleepLongevityAge baseline, consider a first biomarker panel
• Ask your care team whether your CPAP device is still performing well or is due for replacement, especially if it is older than 5 years

This checklist takes less than an hour to complete annually and prevents the gradual accumulation of untreated side effects that leads to therapy abandonment.

TIP: Set a recurring annual reminder to complete this checklist. Most CPAP side effects that seem sudden have actually been building for months without structured follow-up.

KEY TAKEAWAY: A yearly CPAP health review covering mask fit, device data, pressure settings, and biomarker tracking is the most effective way to prevent long-term side effects from undermining therapy adherence.

Even with good maintenance practices, many CPAP users carry misconceptions about what their therapy does and does not cause.

Common Myths About Long-Term CPAP Use Debunked

MYTH: CPAP machines cause lung damage over time.

FACT: CPAP delivers room air at slightly elevated pressure. It does not introduce any chemical, drug, or foreign substance into the lungs. According to the American Academy of Sleep Medicine, there is no evidence that CPAP therapy causes lung damage in patients without pre-existing pulmonary disease. The pressurized air simply splints the airway open. The confusion often stems from recalled devices that used a sound-dampening foam (not present in all CPAP machines), which was a manufacturing issue unrelated to the mechanism of positive airway pressure itself.

MYTH: You become dependent on CPAP and cannot sleep without it.

FACT: CPAP does not create physiological dependence. It treats a structural or anatomical problem (airway collapse during sleep) that exists whether or not the device is present. Stopping CPAP does not cause withdrawal. It simply means obstructive sleep apnea returns to its untreated state. Some patients perceive this as dependence because their sleep quality deteriorates without the device, but that is the disease reasserting itself, not a side effect of treatment.

MYTH: CPAP therapy replaces the need for other health interventions.

FACT: CPAP controls the airway obstruction component of sleep apnea. It does not fix the metabolic damage, weight gain, or cardiovascular strain that years of untreated apnea may have caused. The CDC emphasizes that adults generally need at least 7 hours of sleep per night, but sleep quantity without quality, and without addressing underlying health markers, does not provide full protection. This is why biomarker tracking through services like Dumbo Health's longevity membership provides a more complete picture of recovery.

MYTH: All CPAP masks cause permanent facial marks or structural damage.

FACT: Temporary mask marks after a night of use are normal and harmless. Permanent facial indentation or structural change is extremely rare in adults and is associated with improperly fitted masks worn excessively tight for years. Proper mask fit, headgear tension adjustment, and periodic mask style rotation prevent this outcome entirely.

MYTH: Using a white noise machine is just as effective as CPAP for improving sleep quality.

FACT: A white noise machine can mask environmental noise and improve subjective sleep comfort, but it has no effect on airway obstruction, oxygen desaturation, or the apnea-hypopnea index. It is a sleep environment tool, not a treatment for sleep apnea. Patients who substitute environmental modifications for CPAP therapy leave their obstructive sleep apnea untreated.

KEY TAKEAWAY: The most persistent myths about CPAP therapy confuse equipment-related issues with therapy mechanism issues, or overestimate what CPAP alone can achieve without broader health monitoring.

With these myths addressed, the final question is how to choose the right level of ongoing monitoring for your specific situation.

Choosing the Right Monitoring Approach for Long-Term CPAP Users

The right monitoring approach for a long-term CPAP user depends on the severity of the original diagnosis, the number and intensity of side effects experienced, and whether the goal is limited to airway control or extends to broader longevity and metabolic health.

Standard CPAP Follow-Up vs. Biomarker-Driven Monitoring

What Each Approach Tracks

• Standard CPAP Follow-Up: Residual AHI, mask leak rate, usage hours per night, pressure adequacy
• Biomarker-Driven Monitoring: All standard CPAP metrics plus hs-CRP, HbA1c, cortisol, ApoB, GFR, HRV, and additional longevity markers

Frequency

• Standard CPAP Follow-Up: Typically once a year or when symptoms change
• Biomarker-Driven Monitoring: Twice-yearly blood draws plus continuous or periodic CPAP data review

What It Misses

• Standard CPAP Follow-Up: Systemic inflammation, metabolic disruption, vascular aging, and hormonal imbalance that persist despite adequate AHI control
• Biomarker-Driven Monitoring: Nothing missed that blood biomarkers and CPAP data can jointly capture; does not replace imaging or specialist cardiology evaluation when indicated

Cost

• Standard CPAP Follow-Up: Varies by insurance; copays, deductibles, and prior authorizations can create unpredictable costs
• Biomarker-Driven Monitoring: Dumbo Health Core membership at $0.99 a day ($365 a year) with no insurance required, HSA and FSA eligible, no prior authorizations, and no surprise bills

Best For

• Standard CPAP Follow-Up: Patients with well-controlled mild sleep apnea and no cardiovascular or metabolic risk factors
• Biomarker-Driven Monitoring: Patients with moderate to severe sleep apnea, cardiovascular disease risk, metabolic concerns, or anyone who wants to quantify whether CPAP therapy is actually slowing biological aging

For patients who want the most comprehensive monitoring available, Dumbo Health's Concierge plan includes 103 biomarkers tested twice a year, a dedicated sleep physician with 24/7 access, a personal sleep coach, and all add-on specialty packs included, at $300 a month for early members ($3,600 a year). The Concierge plan is designed for patients who treat sleep not just as a medical issue but as the most controllable input into biological aging.

Blood draws for both plans are available through the Quest Diagnostics network at more than 2,000 locations across 49 states and Washington DC, with in-home mobile phlebotomist draws available in select areas near you. Results typically arrive in about 7 days.

KEY TAKEAWAY: Standard CPAP follow-up confirms the machine is working, but biomarker-driven monitoring confirms your body is actually recovering, and the gap between those two assessments is where preventable long-term health decline happens.

Bringing all of this together, the evidence points clearly toward a specific set of actions.

Conclusion

Long-term CPAP side effects are real but manageable, and they are substantially less harmful than the cardiovascular, metabolic, and cognitive consequences of leaving obstructive sleep apnea untreated. The most common side effects, including dry mouth, nasal congestion, skin irritation, aerophagia, and mask discomfort, respond well to humidification adjustments, mask fit optimization, and periodic pressure settings review. The less visible systemic effects of long-term therapy, both positive (reduced blood pressure, improved metabolic markers) and potentially incomplete (residual inflammation, unresolved vascular aging), require biomarker tracking to assess accurately. If you are on CPAP therapy and want to know whether it is actually slowing your biological aging, the free sleep quiz at Dumbo Health is a practical starting point, with no insurance required, HSA and FSA eligible plans starting at $0.99 a day, and early-member pricing locked for life for the first 500 members.

Frequently Asked Questions About Long-Term Side Effects of CPAP Machines

What is a CPAP machine and what does it do?

A CPAP machine, or continuous positive airway pressure device, delivers a steady stream of pressurized air through a mask worn during sleep. This airflow keeps the upper airway open, preventing the breathing interruptions that characterise obstructive sleep apnea. The machine consists of a motor unit, a flexible tube, and a mask that fits over the nose, mouth, or both. By maintaining consistent air pressure throughout the night, CPAP therapy reduces snoring, prevents oxygen desaturation, and helps restore normal sleep architecture. A healthcare professional determines the appropriate pressure settings based on a sleep study or home sleep apnea test result.

What are the benefits of using a CPAP machine long-term?

Long-term CPAP therapy is associated with reduced daytime sleepiness, improved sleep quality, lower blood pressure, and reduced cardiovascular disease risk in people with obstructive sleep apnea. The American Academy of Sleep Medicine recognises CPAP as the first-line treatment for moderate to severe obstructive sleep apnea. Consistent use can lower systolic and diastolic blood pressure, reduce the recurrence of atrial fibrillation episodes, decrease sympathetic hyperactivity, and improve cognitive function. These benefits depend significantly on adherence, meaning how consistently and for how many hours per night the device is used.

What are the most common long-term side effects of using a CPAP machine?

The most common long-term side effects of CPAP use include dry mouth, nasal congestion, dry nose, skin irritation or pressure sores from the mask, aerophagia (air swallowing), and mask leak. Some people develop dermatitis from mask contact. Over time, poorly fitting masks can cause discomfort and air leakage, which reduces therapy effectiveness. Condensation inside the tube is also a common complaint, particularly in cooler rooms. Most of these side effects are manageable with equipment adjustments, a heated humidifier, or a change in mask style, and a sleep physician or CPAP care team can help identify practical solutions without stopping therapy.

Can long-term CPAP use weaken throat muscles?

Some researchers have raised the question of whether long-term positive airway pressure therapy could reduce the natural muscle tone of the upper airway over time, since the pressurized air mechanically holds the airway open rather than relying on muscle activity. However, this area remains under active investigation and is not a confirmed, well-documented clinical outcome. The established risks of untreated obstructive sleep apnea, including cardiovascular disease, hypertension, and cognitive impairment, are considerably better documented than this theoretical concern. If you have questions about throat muscle tone or airway health during long-term therapy, a sleep physician can review your specific situation.

Can a CPAP machine cause ear problems over time?

Pressurized air delivered by a CPAP machine can occasionally cause ear discomfort, including a sensation of fullness or mild pain in the ear canal, particularly if air pressure settings are high or if the mask fit allows air to travel in unintended directions. Eustachian tube dysfunction can make this more noticeable. Sinus pressure changes associated with CPAP use may also contribute to ear-related symptoms in some users. These issues are not universal and are often addressable by adjusting pressure settings or switching mask styles. If you experience persistent ear pain or pressure, a healthcare professional should evaluate whether a pressure or equipment change is appropriate.

Does long-term CPAP use affect the sinuses or cause sinusitis?

Nasal congestion, dry nose, and sinusitis are among the more frequently reported respiratory side effects of long-term CPAP therapy. Constant airflow through the nasal passages can irritate the mucous membranes, particularly in dry environments or when humidification is insufficient. Using a heated humidifier and a humidifier chamber with your CPAP system can significantly reduce nasal dryness and congestion. A heated humidifier maintains moisture in the delivered air, reducing the risk of mucosal irritation. If sinus symptoms persist or worsen, a healthcare professional should assess whether an underlying sinus condition, pressure setting adjustment, or equipment change is needed.

Can bacteria or mold grow inside a CPAP machine?

Yes, bacteria and mold can accumulate inside a CPAP machine, mask, tube, and humidifier chamber if the equipment is not cleaned regularly. Stagnant water in the humidifier chamber and moisture inside the tube create conditions where microbial growth can occur. Breathing contaminated air from a poorly maintained device may increase the risk of respiratory infections. The American Academy of Sleep Medicine recommends regular cleaning of all CPAP components according to manufacturer guidelines. Mask and tubing should be wiped down or rinsed frequently, and the humidifier chamber should be emptied and dried daily. Full cleaning schedules and replacement intervals vary by component and device model.

How often should I clean my CPAP equipment?

CPAP equipment should be cleaned regularly to prevent bacterial growth, mold, and respiratory infections. General guidance includes rinsing the mask, tubing, and humidifier chamber with warm water and mild soap daily or every few days, and allowing all components to air dry completely before reassembly. The humidifier chamber should be emptied and dried each morning. Filters should be checked and replaced according to the manufacturer's schedule. Mask cushions, headgear, and tubing typically have recommended replacement intervals measured in weeks or months. Following the cleaning schedule for your specific device model helps maintain both hygiene and therapy effectiveness.

Why do some people quit CPAP therapy after long-term use?

Non-adherence remains one of the most significant challenges in long-term CPAP therapy. According to research published in Chest by Bakker, Weaver, Parthasarathy, and Aloia, adherence to CPAP therapy is complex and influenced by mask discomfort, pressure settings, aerophagia, claustrophobia, dry mouth, skin irritation, and a perception that symptoms have resolved. Some people stop because they feel better and underestimate the ongoing risk of untreated obstructive sleep apnea. Regular follow-up, remote monitoring of residual AHI and mask leak data, and access to a CPAP care team meaningfully improve long-term adherence rates. Identifying the specific barrier to use is the first step toward addressing it.

How can I reduce the risks of long-term CPAP use without stopping therapy?

Reducing the risks of long-term CPAP use typically involves consistent equipment maintenance, correct mask fit, appropriate humidification, and regular clinical follow-up. Using a heated humidifier reduces dry mouth, dry nose, and nasal congestion. Switching to a nasal pillow mask or nasal mask can reduce skin irritation and claustrophobia. Mask liners can reduce pressure sores and dermatitis. A chin strap may help with mouth breathing if you use a nasal mask. Auto CPAP or bilevel positive airway pressure may suit people who struggle with fixed pressure settings. A sleep physician can review your adherence data, residual AHI, and mask leak patterns to fine-tune your setup without interrupting therapy.

Should I change my CPAP pressure settings on my own?

No. Pressure settings for CPAP or bilevel PAP therapy should not be changed without clinical guidance. Incorrect pressure settings can cause aerophagia, central sleep apnea events, worsening of residual AHI, or ineffective treatment of obstructive sleep apnea. Some devices, such as auto CPAP systems, automatically adjust within a prescribed pressure range, but the range itself is set by a clinician based on your sleep study or titration data. If your current settings feel uncomfortable or your symptoms have returned, contact your prescribing clinician or CPAP care team to review your therapy data before making changes. Dumbo Health provides physician interpretation and ongoing CPAP support as part of its clinical care pathway.

Is CPAP safe if I also have COPD, diabetes, or high blood pressure?

CPAP therapy is generally considered safe for people with coexisting conditions such as COPD, diabetes, or hypertension, and in many cases it may offer additional benefit. Treating obstructive sleep apnea with CPAP has been associated with reductions in systolic and diastolic blood pressure, including in cases of resistant hypertension, and may reduce reliance on certain antihypertensive drugs such as beta-blockers and calcium channel blockers. However, COPD and central sleep apnea may require different ventilation modes such as bilevel positive airway pressure or adaptive servo-ventilation rather than standard CPAP. A healthcare professional familiar with your full medical history should determine the appropriate therapy type and settings for your specific combination of conditions.

Does CPAP therapy affect body weight or metabolism over time?

The relationship between long-term CPAP therapy and body weight is complex. Research by Redenius, Murphy, O'Neill, Al-Hamwi, and Zallek published in the Journal of Clinical Sleep Medicine found that CPAP use did not consistently lead to changes in BMI. Some studies have examined whether CPAP influences ghrelin plasma levels, leptin resistance, metabolic rate, and body weight regulation, since obstructive sleep apnea disrupts hormonal pathways involved in appetite and energy balance. Results across studies are mixed. CPAP alone is not a weight management intervention, and changes in body weight, abdominal circumference, or neck circumference during CPAP use should be discussed with a healthcare professional in the context of your overall health.

What are the alternatives to CPAP therapy for obstructive sleep apnea?

Alternatives to CPAP therapy include oral appliance therapy, surgery, positional therapy, and lifestyle modification. Oral appliance therapy uses a custom-fitted dental device to reposition the jaw and tongue, keeping the airway open during sleep. It is typically recommended for mild to moderate obstructive sleep apnea or for patients who cannot tolerate CPAP. Dental sleep medicine specialists fit and monitor oral appliances. Surgical options vary depending on the anatomical cause of airway obstruction. Lifestyle changes such as weight loss, reducing alcohol consumption, and changing sleep position can reduce apnea-hypopnea index in some patients. A sleep physician can evaluate which alternative or combination of approaches is appropriate based on your diagnosis and symptom severity.

Can obstructive sleep apnea be reversed without CPAP?

In some people, obstructive sleep apnea can improve significantly through weight loss, positional changes, or other lifestyle modifications, particularly when excess body weight or sleep position is a primary contributing factor. However, complete reversal without treatment is not guaranteed and depends on the severity of the condition, underlying anatomy, and individual health factors. A follow-up sleep study or home sleep apnea test is typically needed to confirm whether apnea-hypopnea index has improved sufficiently to discontinue or modify treatment. Stopping CPAP therapy without clinical confirmation of improvement carries a risk of untreated obstructive sleep apnea returning. A healthcare professional should guide any decision to reduce or discontinue therapy.

What are the long-term cardiovascular effects of untreated sleep apnea compared to CPAP treatment?

Untreated obstructive sleep apnea is associated with increased risk of hypertension, heart disease, stroke, arrhythmia, and arterial stiffness due to repeated episodes of oxygen desaturation and sympathetic hyperactivity during sleep. The NHS lists heart disease, high blood pressure, and stroke among the potential complications of untreated sleep apnea. Long-term CPAP therapy has been associated with reductions in blood pressure, improved arterial stiffness, reduced recurrence of atrial fibrillation episodes, and lower cardiovascular disease risk in observational studies. The degree of cardiovascular benefit depends on adherence, baseline severity, and individual patient factors. A physician can help interpret what these risks mean for your health specifically.

Who should use a CPAP machine?

CPAP therapy is primarily recommended for adults diagnosed with moderate to severe obstructive sleep apnea based on a sleep study or home sleep apnea test, typically defined by an apnea-hypopnea index above 15 events per hour, or above 5 events per hour with significant daytime sleepiness or cardiovascular comorbidities. People with mild obstructive sleep apnea may also benefit, particularly if they experience significant symptoms such as excessive daytime sleepiness, snoring, or high blood pressure. A sleep physician reviews the diagnosis, Epworth Sleepiness Scale score, polysomnography or home sleep test results, and medical history before recommending CPAP or an alternative. CPAP should be prescribed and initiated under clinical supervision, not self-initiated.

Do commercial drivers with sleep apnea need to use CPAP, and does it affect their DOT medical certificate?

Commercial drivers diagnosed with obstructive sleep apnea may need to demonstrate treatment and adherence to maintain their DOT medical certificate, depending on the certified medical examiner's assessment. The FMCSA does not have a single universal federal standard specifically mandating CPAP for all drivers with sleep apnea, but certified medical examiners may apply their clinical judgment and consider treatment adherence, residual AHI, and symptom improvement when making certification decisions. A certified medical examiner, not Dumbo Health, makes all DOT certification decisions. Dumbo Health can support at-home sleep apnea testing and care documentation for commercial drivers in Florida, Texas, Virginia and Maryland. You can read more at the CDL driver sleep apnea testing guide.

How does an at-home sleep apnea test differ from an in-lab sleep study?

A home sleep apnea test, or HSAT, is a simplified FDA-cleared device used in the patient's own bed to measure breathing patterns, oxygen saturation, and airflow overnight. It is designed to diagnose obstructive sleep apnea in adults who are likely to have moderate to severe disease without significant comorbidities. An in-lab sleep study, or polysomnography, is conducted in a clinical setting with full monitoring of brain activity, muscle movement, eye movement, heart rhythm, and respiratory effort, making it the more comprehensive diagnostic tool. The American Academy of Sleep Medicine supports home sleep apnea testing as an appropriate first diagnostic step in many patients. A sleep physician determines which test is appropriate based on your clinical history and symptoms.

How much does an at-home sleep apnea test cost, and does it require insurance?

Dumbo Health offers an at-home sleep apnea test in Florida, Texas, Virginia and Maryland for $149 as a one-time cash-pay purchase, separate from any membership. The test is FDA-cleared and includes the home sleep test device and one night of testing, with physician diagnosis typically provided within 48 hours. No insurance is required, there are no prior authorizations, and there are no surprise bills. This is separate from the longevity membership pricing. For commercial drivers needing sleep apnea evaluation and documentation support, this pathway provides a convenient and transparent option.

What is the SleepLongevityAge score and how does it relate to sleep apnea?

SleepLongevityAge is a proprietary metric developed by Dumbo Health that estimates how sleep may be affecting biological aging, built from blood biomarker data and optional wearable device inputs reviewed by board-certified physicians. Biomarkers such as hs-CRP, HbA1c, cortisol, testosterone, and cardiovascular risk markers like ApoB are included in the panel. Obstructive sleep apnea is one of the most significant sleep-related drivers of accelerated biological aging, operating through pathways including inflammation, metabolic dysregulation, and cardiovascular strain. A high apnea-hypopnea index and untreated sleep apnea can influence many of the biomarkers measured in the sleep longevity panel. Addressing sleep apnea through CPAP therapy may support healthier biomarker profiles over time, though individual outcomes vary.

How can I track whether CPAP therapy is improving my health over time?

Tracking CPAP therapy outcomes over time typically involves reviewing adherence data from the device, monitoring residual AHI, and assessing symptom changes using tools such as the Epworth Sleepiness Scale. Remote monitoring through connected devices such as System One or DreamStation platforms allows clinicians to review mask leak, pressure events, and usage hours without requiring clinic visits. Blood pressure monitoring is also useful given the established relationship between obstructive sleep apnea and hypertension. For a broader picture of how sleep is affecting biological health, biomarker panel testing through Dumbo Health's sleep longevity membership tracks inflammatory, metabolic, hormonal, and cardiovascular markers twice a year, providing a measurable baseline and ongoing comparison over time.

When should I contact a healthcare professional about CPAP side effects?

You should contact a healthcare professional if you experience persistent or worsening symptoms despite CPAP use, including ongoing daytime sleepiness, returning snoring, severe mask discomfort, skin breakdown, chest pain, shortness of breath, or signs of respiratory infection. You should also seek clinical review if your CPAP device is showing high residual AHI or significant mask leak on its monitoring data, or if you are considering stopping therapy. If you have severe symptoms, chest pain, difficulty breathing, or any urgent health concern, seek medical care promptly. Regular follow-up with a sleep physician is an important part of long-term CPAP care, and most treatment decisions, including pressure changes or switching device types, should be made with clinician input. Find a testing location near you if you need blood work or biomarker review as part of your follow-up care.